摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(benzhydrylamino)-phenylmethyl]-hydroxy-oxophosphanium | 115752-21-1

中文名称
——
中文别名
——
英文名称
[(benzhydrylamino)-phenylmethyl]-hydroxy-oxophosphanium
英文别名
α-(Diphenylmethylamino)benzylphosphonous acid;[[(Diphenylmethyl)amino]phenylmethyl]phosphinic acid;(Benzhydrylamino)(phenyl)methylphosphinic acid
[(benzhydrylamino)-phenylmethyl]-hydroxy-oxophosphanium化学式
CAS
115752-21-1
化学式
C20H20NO2P
mdl
——
分子量
337.358
InChiKey
WKAGMVDIBPUFJY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.53
  • 重原子数:
    24.0
  • 可旋转键数:
    6.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    49.33
  • 氢给体数:
    2.0
  • 氢受体数:
    2.0

反应信息

点击查看最新优质反应信息

文献信息

  • AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN
    申请人:Roques Bernard
    公开号:US20110124601A1
    公开(公告)日:2011-05-26
    The present invention relates to a compound of the following general formula (I): R 1 —NH—CH(R 2 )—P(═O)(OR 3 )—CH 2 —C(R 4 )(R 5 )—CONH—CH(R 6 )—COOR 7 (I) or a pharmaceutically acceptable salt of the latter, an isomer or a mixture of isomers in any proportions, especially a mixture of enantiomers, and in particular a racemic mixture, for which R 1 represents a —C(═O)—O—C(R 8 )(R 9 )—OC(═O)—R 10 group; R 2 represents an optionally substituted hydrocarbon-based chain, an aryl or heteroaryl group or a methylene group substituted by a heterocycle; R 3 represents a hydrogen atom or a —C(R 12 )(R 13 )—OC(═O)—R 14 group; R 4 and R 5 form, together with the carbon that bears them, a saturated hydrocarbon-based ring or an optionally substituted piperidine ring or R 4 represents a hydrogen atom and R 5 represents a phenyl or a benzyl that is optionally substituted, a heteroaromatic ring or a methylene group substituted by a heterocycle; R 6 represents an optionally substituted hydrocarbon-based chain or a phenyl or a benzyl that is optionally substituted; and R 7 represents a hydrogen atom or a benzyl, alkyl, heteroaryl, alkylheteroaryl, —CHMe—COOR 18 , —CHR 19 —OC(═O)OR 20 and —CHR 19 —OC(═O)OR 20 group. The present invention also relates to the use of these compounds as a medicinal product, and in particular for the treatment of pain, more advantageously neuropathic and neuroinflammatory pain, to their method of synthesis and also to the compositions containing them.
    本发明涉及以下通式(I)的化合物:R1—NH—CH(R2)—P(═O)(OR3)—CH2—C(R4)(R5)—CONH—CH(R6)—COOR7或其药学上可接受的盐、异构体或任意比例的异构体混合物,特别是对映体混合物,尤其是外消旋混合物,其中R1代表—C(═O)—O—C(R8)(R9)—OC(═O)—R10基团;R2代表可选取代的碳氢链、芳基或杂环芳基基团或被杂环取代的亚甲基基团;R3代表氢原子或—C(R12)(R13)—OC(═O)—R14基团;R4和R5与承载它们的碳原子一起形成饱和碳氢基环或可选取代的哌啶环或R4代表氢原子,R5代表可选取代的苯基或苄基、杂环芳基环或被杂环取代的亚甲基基团;R6代表可选取代的碳氢链或可选取代的苯基或苄基;R7代表氢原子或苄基、烷基、杂环芳基、烷基杂环芳基、—CHMe—COOR18、—CHR19—OC(═O)OR20和—CHR19—OC(═O)OR20基团。本发明还涉及这些化合物作为药物的用途,特别是用于疼痛治疗,更有利的是神经病理性和神经炎性疼痛的治疗,以及它们的合成方法和含有它们的组合物。
  • Aminophosphinic derivatives that can be used in the treatment of pain
    申请人:PHARMALEADS
    公开号:US10131681B2
    公开(公告)日:2018-11-20
    The present invention relates to a compound of the following general formula (I): R1—NH—CH(R2)—P(═O)(OR3)—CH2—C(R4)(R5)—CONH—CH(R6)—COOR7 (I) or a pharmaceutically acceptable salt of the latter, an isomer or a mixture of isomers in any proportions, especially a mixture of enantiomers, and in particular a racemic mixture, for which R1 represents a —C(═O)—O—C(R8)(R9)—OC(═O)—R10 group; R2 represents an optionally substituted hydrocarbon-based chain, an aryl or heteroaryl group or a methylene group substituted by a heterocycle; R3 represents a hydrogen atom or a —C(R12)(R13)—OC(═O)—R14 group; R4 and R5 form, together with the carbon that bears them, a saturated hydrocarbon-based ring or an optionally substituted piperidine ring or R4 represents a hydrogen atom and R5 represents a phenyl or a benzyl that is optionally substituted, a heteroaromatic ring or a methylene group substituted by a heterocycle; R6 represents an optionally substituted hydrocarbon-based chain or a phenyl or a benzyl that is optionally substituted; and R7 represents a hydrogen atom or a benzyl, alkyl, heteroaryl, alkylheteroaryl, —CHMe-COOR18, —CHR19—OC(═O)R20 and —CHR19—OC(═O)OR20 group. The present invention also relates to the use of these compounds as a medicinal product, and in particular for the treatment of pain, more advantageously neuropathic and neuroinflammatory pain, to their method of synthesis and also to the compositions containing them.
    本发明涉及以下通式(I)的化合物:R1-NH-CH(R2)-P(═O)(OR3)-CH2-C(R4)(R5)-CONH-CH(R6)-COOR7(I)或后者的药学上可接受的盐、异构体或任何比例的异构体混合物,特别是对映体混合物,尤其是外消旋混合物,其中R1代表-C(═O)-O-C(R8)(R9)-OC(═O)-R10基团;R2 代表任选取代的烃基链、芳基或杂芳基或被杂环取代的亚甲基; R3 代表氢原子或-C(R12)(R13)-OC(═O)-R14 基团;R4 和 R5 与含有它们的碳一起形成饱和烃基环或任选取代的哌啶环,或 R4 代表氢原子,R5 代表任选取代的苯基或苄基、杂芳环或被杂环取代的亚甲基;R6 代表任选取代的烃基链或任选取代的苯基或苄基;以及 R7 代表氢原子或苄基、烷基、杂芳基、烷基杂芳基、-CHMe-COR18、-CHR19-OC(═O)R20 和-CHR19-OC(═O)OR20 基团。本发明还涉及这些化合物作为医药产品的用途,特别是用于治疗疼痛,尤其是神经病理性疼痛和神经炎性疼痛,还涉及它们的合成方法以及含有它们的组合物。
  • Synthesis of α1-(Cbz-aminoalkyl)-α2-(hydroxyalkyl)phosphinic esters
    作者:Marcin Drag、Józef Oleksyszyn
    DOI:10.1016/j.tetlet.2005.03.083
    日期:2005.5
    A synthesis of alpha(1)-(Cbz-aminoalkyl)-alpha(2)-(hydroxyalkyl)phosphinic esters was achieved by the 1,2-addition of the appropriate aldehyde to Cbz-protected phosphinic analogues of amino acid esters in the presence of at least three equivalents of trimethylsilyl chloride and NEt3. The complete deprotection of the product esters could be achieved in one step using 35% HBr in acetic acid. (c) 2005 Elsevier Ltd. All rights reserved.
  • DE2722162
    申请人:——
    公开号:——
    公开(公告)日:——
  • GROBELNY, DAMIAN, SYNTHESIS,(1987) N 10, 942-943
    作者:GROBELNY, DAMIAN
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐